Page last updated: 2024-09-04

ym 09151-2 and Atherosclerotic Parkinsonism

ym 09151-2 has been researched along with Atherosclerotic Parkinsonism in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Isozaki, S; Kariya, S; Masubuchi, Y; Narimatsu, S; Suzuki, T	1

Other Studies

1 other study(ies) available for ym 09151-2 and Atherosclerotic Parkinsonism

Article	Year
Possible pharmacokinetic and pharmacodynamic factors affecting parkinsonism inducement by cinnarizine and flunarizine. Biochemical pharmacology, 1995, Nov-09, Volume: 50, Issue:10 Topics: Animals; Benzamides; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Cinnarizine; Corpus Striatum; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Administration Schedule; Female; Flunarizine; Parkinson Disease, Secondary; Rats; Rats, Wistar; Receptors, Dopamine D2; Tritium	1995

Article

Year

Possible pharmacokinetic and pharmacodynamic factors affecting parkinsonism inducement by cinnarizine and flunarizine.

Biochemical pharmacology, 1995, Nov-09, Volume: 50, Issue:10

Topics: Animals; Benzamides; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Cinnarizine; Corpus Striatum; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Administration Schedule; Female; Flunarizine; Parkinson Disease, Secondary; Rats; Rats, Wistar; Receptors, Dopamine D2; Tritium

1995